Simalatsar, AlenaYou, WenqiSun, DechaoGotta, VerenaWidmer, NicolasDe Micheli, Giovanni2013-12-052013-12-052013-12-052013https://infoscience.epfl.ch/handle/20.500.14299/97464In this paper we present a prototype of a control flow for an a posteriori drug dose adaptation for Chronic Myelogenous Leukemia (CML) patients. The control flow is modeled using Timed Automata extended with Tasks (TAT) model. The feedback loop of the control flow includes the decision-making process for drug dose adaptation. This is based on the outputs of the body response model represented by the Support Vector Machine (SVM) algorithm for drug concentration prediction. The decision is further checked for conformity with the dose level rules of a medical guideline. We also have developed an automatic code synthesizer for the <i>icycom</i> platform as an extension of the TIMES tool.control flowpersonalizationmedical guidelinescode synthesisA Control Flow Prototype for a Dose Recommending Device for Chronic Myeloid Leukemia Patientstext::conference output::conference paper not in proceedings